US Stock MarketDetailed Quotes

Nektar Therapeutics (NKTR)

Watchlist
  • 36.530
  • -0.390-1.06%
Close Jan 22 16:00 ET
  • 37.000
  • +0.470+1.29%
Pre 05:40 ET
743.08MMarket Cap-4.83P/E (TTM)

Nektar Therapeutics (NKTR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
36.64%-192.61M
18.47%-47.05M
Net income from continuing operations
4.14%-35.52M
20.57%-41.59M
-38.26%-50.88M
56.91%-118.96M
117.26%7.26M
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
Operating gains losses
--534K
--2.39M
--4.46M
-731.19%-40.39M
----
----
----
----
117.41%6.4M
----
Depreciation and amortization
-80.26%196K
-85.33%214K
-73.49%426K
-43.81%4.39M
-79.90%332K
-41.42%993K
-32.64%1.46M
-30.19%1.61M
-40.02%7.82M
-48.08%1.65M
Deferred tax
----
----
----
----
----
-106.67%-31K
311.11%57K
97.90%-38K
----
----
Other non cash items
43.95%-5.44M
39.10%-4.46M
47.78%-6.81M
17.05%-36.16M
45.64%-6.09M
20.77%-9.71M
-11.72%-7.32M
4.01%-13.04M
-21.30%-43.59M
-7.37%-11.19M
Change In working capital
-1,056.26%-10.17M
-132.97%-3.58M
97.81%-146K
68.71%-6.24M
-136.10%-11.5M
132.87%1.06M
216.03%10.86M
-169.16%-6.66M
-4,152.85%-19.94M
39.61%-4.87M
-Change in receivables
--0
--0
--0
-163.76%-3.05M
-320.62%-2.2M
2.19%-850K
45.84%2.42M
-180.78%-2.41M
-71.07%4.78M
-82.00%999K
-Change in inventory
--0
--0
--0
-28.90%497K
21.85%1.31M
-94.80%123K
128.12%212K
42.42%-1.14M
120.55%699K
838.62%1.07M
-Change in payables and accrued expense
-165.06%-5.72M
-111.98%-799K
818.67%7.63M
166.51%13.4M
12.41%-2.89M
713.32%8.79M
162.67%6.67M
111.40%830K
-19.62%-20.15M
76.84%-3.3M
-Change in other current assets
82.73%-618K
-64.73%985K
-510.45%-5.96M
-216.86%-4.19M
-179.82%-2.43M
-3.65%-3.58M
20.86%2.79M
-117.46%-976K
-48.12%3.58M
-142.40%-867K
-Change in other working capital
-11.77%-3.83M
-204.28%-3.77M
38.71%-1.81M
-45.82%-12.91M
-90.66%-5.29M
-45.02%-3.42M
35.89%-1.24M
-65.62%-2.96M
-230.22%-8.85M
-120.53%-2.77M
Cash from discontinued investing activities
Operating cash flow
-10.99%-48.76M
-21.31%-45.74M
-2.43%-49.05M
8.77%-175.71M
1.83%-46.19M
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
36.64%-192.61M
18.47%-47.05M
Investing cash flow
Cash flow from continuing investing activities
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
-61.85%139.56M
-56.56%17.38M
Net PPE purchase and sale
82.88%-114K
80.11%-37K
98.73%-2K
-486.32%-1.47M
-93.67%-459K
-154.95%-666K
-14.81%-186K
63.74%-157K
-94.95%380K
-101.87%-237K
Net business purchase and sale
----
----
----
--65.39M
----
----
----
----
--0
----
Net investment purchase and sale
-302.55%-94.76M
189.21%49.65M
128.63%44.39M
-43.49%78.65M
-126.75%-4.71M
-15.25%46.78M
-32.23%17.17M
-52.68%19.42M
-61.16%139.18M
-35.53%17.62M
Net other investing changes
--0
--0
---697K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-305.73%-94.87M
192.16%49.62M
126.86%43.69M
2.15%142.57M
246.40%60.21M
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
-61.85%139.56M
-56.56%17.38M
Financing cash flow
Cash flow from continuing financing activities
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
13K
5.56%19K
42M
-98.01%30K
-88.35%12K
Net common stock issuance
--142.59M
--0
--0
---3M
--0
--0
--0
---3M
--0
--0
Proceeds from stock option exercised by employees
1,730.77%238K
1,010.53%211K
-99.98%7K
100,293.33%30.12M
591.67%83K
--13K
5.56%19K
--30M
-96.04%30K
-88.35%12K
Net other financing activities
----
----
----
--15M
--0
--0
--0
--15M
----
----
Cash from discontinued financing activities
Financing cash flow
1,089,723.08%141.68M
1,010.53%211K
-99.98%7K
140,293.33%42.12M
591.67%83K
--13K
5.56%19K
--42M
-98.01%30K
-88.35%12K
Net cash flow
Beginning cash position
53.86%42.99M
-20.04%38.89M
25.44%44.25M
-60.02%35.28M
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
-60.02%35.28M
249.86%88.23M
-38.61%64.92M
Current changes in cash
-189.08%-1.96M
119.75%4.09M
-140.06%-5.36M
116.94%8.98M
147.59%14.11M
-84.63%2.2M
21.39%-20.7M
218.17%13.37M
-183.70%-53.01M
-68.61%-29.65M
Effect of exchange rate changes
103.57%1K
700.00%6K
87.50%-1K
-106.45%-4K
312.50%33K
71.43%-28K
-100.93%-1K
-117.78%-8K
118.96%62K
-85.45%8K
End cash Position
36.28%41.03M
53.86%42.99M
-20.04%38.89M
25.44%44.25M
25.44%44.25M
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
-60.02%35.28M
-60.02%35.28M
Free cash flow
-9.59%-48.88M
-20.82%-45.78M
-2.10%-49.06M
8.42%-177.18M
1.35%-46.65M
-5.80%-44.6M
26.69%-37.89M
8.22%-48.05M
37.53%-193.47M
18.78%-47.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M7.76%-47.89M36.64%-192.61M18.47%-47.05M
Net income from continuing operations 4.14%-35.52M20.57%-41.59M-38.26%-50.88M56.91%-118.96M117.26%7.26M19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M
Operating gains losses --534K--2.39M--4.46M-731.19%-40.39M----------------117.41%6.4M----
Depreciation and amortization -80.26%196K-85.33%214K-73.49%426K-43.81%4.39M-79.90%332K-41.42%993K-32.64%1.46M-30.19%1.61M-40.02%7.82M-48.08%1.65M
Deferred tax ---------------------106.67%-31K311.11%57K97.90%-38K--------
Other non cash items 43.95%-5.44M39.10%-4.46M47.78%-6.81M17.05%-36.16M45.64%-6.09M20.77%-9.71M-11.72%-7.32M4.01%-13.04M-21.30%-43.59M-7.37%-11.19M
Change In working capital -1,056.26%-10.17M-132.97%-3.58M97.81%-146K68.71%-6.24M-136.10%-11.5M132.87%1.06M216.03%10.86M-169.16%-6.66M-4,152.85%-19.94M39.61%-4.87M
-Change in receivables --0--0--0-163.76%-3.05M-320.62%-2.2M2.19%-850K45.84%2.42M-180.78%-2.41M-71.07%4.78M-82.00%999K
-Change in inventory --0--0--0-28.90%497K21.85%1.31M-94.80%123K128.12%212K42.42%-1.14M120.55%699K838.62%1.07M
-Change in payables and accrued expense -165.06%-5.72M-111.98%-799K818.67%7.63M166.51%13.4M12.41%-2.89M713.32%8.79M162.67%6.67M111.40%830K-19.62%-20.15M76.84%-3.3M
-Change in other current assets 82.73%-618K-64.73%985K-510.45%-5.96M-216.86%-4.19M-179.82%-2.43M-3.65%-3.58M20.86%2.79M-117.46%-976K-48.12%3.58M-142.40%-867K
-Change in other working capital -11.77%-3.83M-204.28%-3.77M38.71%-1.81M-45.82%-12.91M-90.66%-5.29M-45.02%-3.42M35.89%-1.24M-65.62%-2.96M-230.22%-8.85M-120.53%-2.77M
Cash from discontinued investing activities
Operating cash flow -10.99%-48.76M-21.31%-45.74M-2.43%-49.05M8.77%-175.71M1.83%-46.19M-4.30%-43.93M26.82%-37.7M7.76%-47.89M36.64%-192.61M18.47%-47.05M
Investing cash flow
Cash flow from continuing investing activities -305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M-52.56%19.26M-61.85%139.56M-56.56%17.38M
Net PPE purchase and sale 82.88%-114K80.11%-37K98.73%-2K-486.32%-1.47M-93.67%-459K-154.95%-666K-14.81%-186K63.74%-157K-94.95%380K-101.87%-237K
Net business purchase and sale --------------65.39M------------------0----
Net investment purchase and sale -302.55%-94.76M189.21%49.65M128.63%44.39M-43.49%78.65M-126.75%-4.71M-15.25%46.78M-32.23%17.17M-52.68%19.42M-61.16%139.18M-35.53%17.62M
Net other investing changes --0--0---697K----------------------------
Cash from discontinued investing activities
Investing cash flow -305.73%-94.87M192.16%49.62M126.86%43.69M2.15%142.57M246.40%60.21M-18.25%46.12M-32.53%16.98M-52.56%19.26M-61.85%139.56M-56.56%17.38M
Financing cash flow
Cash flow from continuing financing activities 1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K13K5.56%19K42M-98.01%30K-88.35%12K
Net common stock issuance --142.59M--0--0---3M--0--0--0---3M--0--0
Proceeds from stock option exercised by employees 1,730.77%238K1,010.53%211K-99.98%7K100,293.33%30.12M591.67%83K--13K5.56%19K--30M-96.04%30K-88.35%12K
Net other financing activities --------------15M--0--0--0--15M--------
Cash from discontinued financing activities
Financing cash flow 1,089,723.08%141.68M1,010.53%211K-99.98%7K140,293.33%42.12M591.67%83K--13K5.56%19K--42M-98.01%30K-88.35%12K
Net cash flow
Beginning cash position 53.86%42.99M-20.04%38.89M25.44%44.25M-60.02%35.28M-53.62%30.11M-44.92%27.94M-36.79%48.64M-60.02%35.28M249.86%88.23M-38.61%64.92M
Current changes in cash -189.08%-1.96M119.75%4.09M-140.06%-5.36M116.94%8.98M147.59%14.11M-84.63%2.2M21.39%-20.7M218.17%13.37M-183.70%-53.01M-68.61%-29.65M
Effect of exchange rate changes 103.57%1K700.00%6K87.50%-1K-106.45%-4K312.50%33K71.43%-28K-100.93%-1K-117.78%-8K118.96%62K-85.45%8K
End cash Position 36.28%41.03M53.86%42.99M-20.04%38.89M25.44%44.25M25.44%44.25M-53.62%30.11M-44.92%27.94M-36.79%48.64M-60.02%35.28M-60.02%35.28M
Free cash flow -9.59%-48.88M-20.82%-45.78M-2.10%-49.06M8.42%-177.18M1.35%-46.65M-5.80%-44.6M26.69%-37.89M8.22%-48.05M37.53%-193.47M18.78%-47.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More